key: cord-0783981-f3jqaf77 authors: Loffredo, Lorenzo; Pacella, Fernanda; Pacella, Elena; Tiscione, Giulia; Oliva, Alessandra; Violi, Francesco title: Conjunctivitis and COVID‐19: A meta‐analysis date: 2020-05-22 journal: J Med Virol DOI: 10.1002/jmv.25938 sha: 77fe36a2b617ba4a7f2dc345772b3879336564b3 doc_id: 783981 cord_uid: f3jqaf77 There are sparse data in literature regarding conjunctivitis incidence in COVID-19 and its relationship with disease severity. The objective of this metanalysis was to assess the association between conjunctivitis and the severity of COVID-19 disease. METHODS We performed a meta-analysis with studies that included patients with severe vs non-severe form of COVID-19 infection. Severe COVID-19 infection was defined as severe pneumonia, mortality, acute respiratory distress syndrome (ARDS), use of mechanical ventilation or Intensive Care Unit (ICU) treatment. RESULTS Three studies, including 1167 patients, reported the incidence of conjunctivitis at admission to the hospital. The overall rate of conjunctivitis was 1.1%; it was 3% and 0.7% in severe and non-severe COVID-19 patients, respectively. Patients with severe COVID-19 had an increased incidence of conjunctivitis (O.R.:3.4; 95% C.I.:1.1-10.2; p=0.030). CONCLUSIONS Conjunctivitis is more frequent in severe COVID and may be a warning sign of poor outcomes. This article is protected by copyright. All rights reserved. Until now, the exact transmission route of COVID-19 remains unclear. The respiratory tract probably is not the only transmission route for this viral infection; some authors hypothesized that COVID-19 droplets, or infected hands, can also contaminate the conjunctiva, that could represent the initial site of a spread infection. 2 The conjunctivitis, also called "Pink eye," is a frequent disease and its etiology could be bacterial or viral. This has been previously described as associated to coronavirus infection in humans and animals. 3 Recent studies showed that conjunctivitis could be a manifestation of COVID-19. 4 Because the eye could be considered as a direct potential portal of entry for the virus, 5 it is of interest to analyze the association between conjunctivitis and the severity of COVID-19; scarce and conflicting data have been reported. In particular, only three studies in Chinese population described this topic, 2 with different results. Xia et al 6 did not find an increased incidence of conjunctivitis in severe COVID-19; they performed a prospective study in 30 COVID-19 patients to assess the presence of the virus in the tears. 6 Previous studies reported about eye infection and conjunctivitis in animals and humans infected by coronavirus. 3 However, the role of conjunctiva in COVID-19 still remains unclear. 8, 9 The results of this study could have important clinical im- Future studies in other populations will be necessary to confirm the results of this meta-analysis. In conclusion, the results of this meta-analysis show that conjunctivitis may represent a sign of COVID-19 infection associated to a more severe form of disease and suggest the use of protective equipment for all people potentially exposed to infected subjects. Hypercoagulation and anti-thrombotic treatment in COVID-19: a new challenge Clinical Characteristics of Coronavirus Disease 2019 in China Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals The possibility of COVID-19 transmission from eye to nose Ocular tropism of respiratory viruses Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto Additional supporting information may be found online in the Supporting Information section.